Our finding that Met is an upstream regulator of IL-8 secretion is significant and suggests one mechanism by which Met signaling could regulate pancreatic cancer in vivo, a novel finding that may provide unique opportunities for clinical intervention. The gene discussed is CXCL8; the disease is familial pancreatic carcinoma.